Skip to main content
logo
BioXcel Therapeutics, Inc. (BTAIQ)
OTCMKTS · Delayed Price · Currency is USD
0.041095
+0.002695 (7.02%)
At close: Sep 28, 2026

BioXcel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1351986602569
Market Cap Growth
-97.57%88.57%-78.51%-85.65%5.82%-49.47%
Enterprise Value
931088396462317
Last Close Price
0.041.605.9847.20343.68325.28

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.7354.508.1962.581605.17-
PB Ratio
-0.01-0.37-0.20-1.537.842.57
P/TBV Ratio
----7.842.57

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
125.20168.3836.6969.821233.33-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.90-1.15-1.10-1.791.220.01
Net Debt / Equity Ratio
-0.79-0.85-0.78-0.63-1.30-1.05
Net Debt / EBITDA Ratio
-2.06-1.63-1.13-0.210.632.17
Net Debt / FCF Ratio
-1.80-1.41-1.01-0.230.742.81
Asset Turnover
0.030.020.040.010.00-
Inventory Turnover
0.700.231.610.63--
Quick Ratio
0.090.531.352.405.9013.98
Current Ratio
0.210.831.682.656.1714.21
Return on Equity (ROE)
----1766.94%-111.08%-49.93%
Return on Assets (ROA)
-102.43%-75.47%-72.30%-74.95%-44.81%-29.10%
Return on Capital Employed (ROCE)
41.30%557.90%-402.40%-361.00%-92.30%-48.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5507.97%-199.76%-321.18%-207.35%-27.54%-18.80%
FCF Yield
-3956.79%-164.66%-388.15%-179.52%-22.51%-14.52%
Buyback Yield / Dilution
-389.70%-381.58%-39.21%-4.00%-6.23%-21.63%